Clinical Trial Update: PNEUMOSTEM® for Improving Respiratory Outcomes in Very Premature Infants Diagnosed With Early Pulmonary Arterial Hypertension [Phase 1]

View source ↗

Summary

A Phase 1 trial of PNEUMOSTEM for improving respiratory outcomes in very premature infants with early pulmonary arterial hypertension; the study is currently no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• PNEUMOSTEM

Snippet

Sponsor: Samsung Medical Center | Conditions: Pulmonary Arterial Hypertension (PAH), Premature Infants | Phase 1 | Status: NOT_YET_RECRUITING